The CAC meets bi-monthly on the second Monday of the month. The CAC creates a unique forum to provide education to our members and policy makers, and coalesce around policy issues that impact patient access to behavioral health treatment.
Webinar: The Utility of Long Acting Medications During COVID-19 and Beyond
August 10, 2020
We are proud to have hosted a successful webinar on August 10, 2020 with our partners from Janssen Pharmaceutical Companies of Johnson & Johnson. Among the 60 attendees was Assembly Member Dr. Joaquin Arambula, who provided welcome remarks to our audience and discussed the importance of patient access to quality behavioral health treatment and medications. The webinar highlighted the efficacy of Long Acting Medications (LAMs) that can serve as an optimal treatment modality for a variety of disorders during and beyond the COVID-19 pandemic.
For meeting materials and to read the recap of the webinar, click here.
Save the date for Part II of this discussion scheduled for October 12th, 2020, and stay tuned for updates and more information in our September Newsletter!